股本结构
单位：万股
| 公告日期 | 2026-10-05 | 2026-09-02 | 2026-08-11 | 2026-06-30 | 2026-06-23 | 2026-06-23 |
|---|---|---|---|---|---|---|
| 证券总股本 | 268.87 | 103.26 | 66.70 | 1737.60 | 1184.97 | 1157.26 |
| 普通股本 | 268.87 | 103.26 | 66.70 | 1737.60 | 1184.97 | 1157.26 |
| 优先股 | 未披露 | 未披露 | 29.06 | 29.06 | 29.06 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-10-01 | 2026-08-31 | 2026-08-10 | 2026-07-01 | 2026-06-08 | 2026-03-11 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-10-05 | 268.87 | 未披露 | 定期报告 | 2026-10-01 |
| 2026-09-02 | 103.26 | 未披露 | 定期报告 | 2026-08-31 |
| 2026-08-11 | 66.70 | 29.06 |
更多>>
a 1-for-35 reverse stock split of the Company's issued and outstanding common stock
|
2026-08-10 |
| 2026-06-30 | 1737.60 | 29.06 |
更多>>
Common stock offered 5,526,315 shares by the company
|
2026-07-01 |
| 2026-06-23 | 1184.97 | 29.06 | 定期报告 | 2026-06-08 |
| 2026-05-15 | 1157.34 | 未披露 | 定期报告 | 2026-05-15 |
| 2026-05-15 | 1129.64 | 29.06 |
更多>>
From December 31, 2025 to March 31, 2026
Release of restricted stock units
|
2026-03-31 |
| 2026-03-27 | 1129.64 | 未披露 | 定期报告 | 2026-03-27 |
| 2026-06-23 | 1157.26 | 未披露 | 定期报告 | 2026-03-11 |
| 2026-03-27 | 1085.13 | 29.06 |
更多>>
From December 31, 2024 to December 31, 2025
Issuance of common stock upon conversion of Series A convertible preferred stock
Issuance of common stock, pre-funded warrants and warrants under inducement agreement, net of issuance costs
Issuance of common stock, prefunded warrants, and warrants, net of issuance costs
Shares issued for acquisition of assets of SiVantage, Inc.
Issuance of common stock and warrants, net of issuance costs
Release of restricted stock units
|
2025-12-31 |
| 2025-12-10 | 1110.64 | 未披露 | 定期报告 | 2025-12-08 |
| 2025-11-17 | 1082.36 | 未披露 |
更多>>
Common Stock offered 2,217,904 shares by the company
|
2025-11-14 |
| 2025-11-13 | 860.57 | 未披露 | 定期报告 | 2025-11-13 |
| 2025-11-13 | 860.55 | 29.06 |
更多>>
From June 30, 2025 to September 30, 2025
Issuance of common stock upon conversion of Series A convertible preferred stock
Release of restricted stock units
Shares issued for acquisition of assets of SiVantage, Inc.
|
2025-09-30 |
| 2025-08-13 | 887.92 | 未披露 | 定期报告 | 2025-08-13 |
| 2025-08-07 | 789.22 | 29.06 | 定期报告 | 2025-08-01 |
| 2025-08-13 | 759.22 | 34.34 |
更多>>
From March 31, 2025 to June 30, 2025
Release of restricted stock units
|
2025-06-30 |
| 2025-06-17 | 759.00 | 34.34 | 定期报告 | 2025-06-06 |
| 2025-05-13 | 759.00 | 未披露 | 定期报告 | 2025-05-13 |
| 2025-05-13 | 759.00 | 34.34 |
更多>>
From December 31, 2024 to March 31, 2025
Issuance of common stock, pre-funded warrants and warrants under inducement agreement, net of issuance costs
Issuance of common stock, prefunded warrants, and warrants, net of issuance costs
Release of restricted stock units
|
2025-03-31 |
| 2025-03-26 | 620.00 | 未披露 |
更多>>
Common stock offered 615,000 shares by the company
|
2025-03-26 |
| 2025-03-26 | 558.50 | 未披露 | 定期报告 | 2025-03-25 |
| 2025-03-26 | 313.88 | 34.34 |
更多>>
From December 31, 2023 to December 31, 2024
Issuance of common stock upon exercise of prefunded warrants
Issuance of common stock, prefunded warrants, and warrants, net of issuance costs
Issuance of common stock for reverse stock split
Issuance of Series B preferred stock and warrants, net of issuance costs
Issuance of common stock, net of issuance costs
Release of restricted stock units
Issuance of Series A preferred stock and warrants, net of issuance costs
Issuance of common stock and warrants under inducement agreement, net of issuance costs
Issuance of common stock upon exercise of warrants
|
2024-12-31 |
| 2024-11-14 | 313.66 | 未披露 | 定期报告 | 2024-11-14 |
| 2024-11-14 | 313.60 | 34.34 |
更多>>
From June 30, 2024 to September 30, 2024
Issuance of common stock, prefunded warrants, and warrants, net of issuance costs
Issuance of common stock upon exercise of prefunded warrants
Issuance of common stock and warrants under inducement agreement
Issuance of common stock upon exercise of warrants
Issuance of common stock, net of issuance costs
Issuance of common stock for reverse stock split
|
2024-09-30 |
| 2024-09-16 | 56.52 | 未披露 |
更多>>
Securities offered 55,000 shares of common stock by the company
|
2024-09-16 |
| 2024-09-09 | 51.02 | 未披露 |
更多>>
a 1:8 reverse stock split of the Company's issued and outstanding common stock
|
2024-09-06 |
| 2024-08-13 | 395.18 | 未披露 | 定期报告 | 2024-08-13 |
| 2024-07-02 | 378.08 | 25.70 | 定期报告 | 2024-06-20 |
| 2024-06-13 | 378.08 | 25.70 | 定期报告 | 2024-06-13 |
| 2024-05-15 | 372.95 | 未披露 | 定期报告 | 2024-05-14 |
| 2024-05-15 | 372.70 | 25.70 |
更多>>
From December 31, 2023 to March 31, 2024
Issuance of series A convertible preferred stock, net of issuance costs
Issuance of common stock, net of issuance costs
Release of restricted stock units
|
2024-03-31 |
| 2024-03-29 | 372.70 | 未披露 | 定期报告 | 2024-03-29 |
| 2024-03-29 | 260.03 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of common stock, net of issuance costs
Issuance of common stock upon exercise of warrants
Shares issued for reverse stock split
Release of restricted stock units
Issuance of common stock and warrants, net of issuance costs
Common stock issued for services
|
2023-12-31 |
| 2023-11-22 | 247.10 | 未披露 | 定期报告 | 2023-11-09 |
| 2023-11-01 | 226.13 | 未披露 |
更多>>
Tenon Medical, Inc. announced, a 1:10 reverse stock split of the Company's issued and outstanding common stock.
|
2023-11-02 |
| 2023-08-11 | 2261.29 | 未披露 | 定期报告 | 2023-08-11 |
| 2023-08-11 | 2162.38 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock and warrants, net of issuance costs
Release of restricted stock units
|
2023-06-30 |
| 2023-06-20 | 2324.75 | 未披露 |
更多>>
Units offered by the company 10,000,000 Units.
|
2023-06-16 |
| 2023-06-07 | 1162.38 | 未披露 | 定期报告 | 2023-06-02 |
| 2023-03-10 | 1125.13 | 未披露 | 定期报告 | 2023-03-10 |
| 2023-03-10 | 1123.68 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Common stock issued upon conversion of Series A preferred stock
Common stock issued upon conversion of Series B preferred stock
Issuance of common stock and warrants, net of issuance costs
Common stock issued upon conversion of debt
Common stock issued for services
|
2022-12-31 |
| 2022-04-27 | 1123.68 | 未披露 |
更多>>
1.Common stock offered by company 3,200,000 shares.
|
2022-04-27 |
a 1-for-35 reverse stock split of the Company's issued and outstanding common stock
Common stock offered 5,526,315 shares by the company
From December 31, 2025 to March 31, 2026
Release of restricted stock units
From December 31, 2024 to December 31, 2025
Issuance of common stock upon conversion of Series A convertible preferred stock
Issuance of common stock, pre-funded warrants and warrants under inducement agreement, net of issuance costs
Issuance of common stock, prefunded warrants, and warrants, net of issuance costs
Shares issued for acquisition of assets of SiVantage, Inc.
Issuance of common stock and warrants, net of issuance costs
Release of restricted stock units
Common Stock offered 2,217,904 shares by the company
From June 30, 2025 to September 30, 2025
Issuance of common stock upon conversion of Series A convertible preferred stock
Release of restricted stock units
Shares issued for acquisition of assets of SiVantage, Inc.
From March 31, 2025 to June 30, 2025
Release of restricted stock units
From December 31, 2024 to March 31, 2025
Issuance of common stock, pre-funded warrants and warrants under inducement agreement, net of issuance costs
Issuance of common stock, prefunded warrants, and warrants, net of issuance costs
Release of restricted stock units
Common stock offered 615,000 shares by the company
From December 31, 2023 to December 31, 2024
Issuance of common stock upon exercise of prefunded warrants
Issuance of common stock, prefunded warrants, and warrants, net of issuance costs
Issuance of common stock for reverse stock split
Issuance of Series B preferred stock and warrants, net of issuance costs
Issuance of common stock, net of issuance costs
Release of restricted stock units
Issuance of Series A preferred stock and warrants, net of issuance costs
Issuance of common stock and warrants under inducement agreement, net of issuance costs
Issuance of common stock upon exercise of warrants
From June 30, 2024 to September 30, 2024
Issuance of common stock, prefunded warrants, and warrants, net of issuance costs
Issuance of common stock upon exercise of prefunded warrants
Issuance of common stock and warrants under inducement agreement
Issuance of common stock upon exercise of warrants
Issuance of common stock, net of issuance costs
Issuance of common stock for reverse stock split
Securities offered 55,000 shares of common stock by the company
a 1:8 reverse stock split of the Company's issued and outstanding common stock
From December 31, 2023 to March 31, 2024
Issuance of series A convertible preferred stock, net of issuance costs
Issuance of common stock, net of issuance costs
Release of restricted stock units
From December 31, 2022 to December 31, 2023
Issuance of common stock, net of issuance costs
Issuance of common stock upon exercise of warrants
Shares issued for reverse stock split
Release of restricted stock units
Issuance of common stock and warrants, net of issuance costs
Common stock issued for services
Tenon Medical, Inc. announced, a 1:10 reverse stock split of the Company's issued and outstanding common stock.
From March 31, 2023 to June 30, 2023
Issuance of common stock and warrants, net of issuance costs
Release of restricted stock units
Units offered by the company 10,000,000 Units.
From December 31, 2021 to December 31, 2022
Common stock issued upon conversion of Series A preferred stock
Common stock issued upon conversion of Series B preferred stock
Issuance of common stock and warrants, net of issuance costs
Common stock issued upon conversion of debt
Common stock issued for services
1.Common stock offered by company 3,200,000 shares.